Company Filing History:
1 out of 1 
1 out of 3 
1 out of 10 
Years Active: 2011-2014
Title: Innovations and Contributions of Inventor Maxim Bespalov in Neurological Research
Introduction: Maxim Bespalov, an accomplished inventor based in Helsinki, Finland, has made significant strides in the field of neurological research and therapy. With a portfolio of three patents, Bespalov focuses on utilizing innovative compounds and methods to enhance neural cell survival and treat various neurological disorders.
Latest Patents: Among his notable patents, the first one outlines methods of facilitating neural cell survival using GDNF family ligand (GFL) mimetics or RET signaling pathway activators. This invention discloses compounds and methods aimed at treating neurological and other disorders by administering effective amounts of compounds that exhibit binding and modulation specificity for GFRα receptor molecules. These compounds include mimetics of glial-derived neurotrophic factor (GDNF) family ligands, GFRα/RET signaling pathway agonists, and direct RET agonists.
His second patent involves Neurturin molecules, which are characterized by reduced heparin and heparan sulfate binding affinity while retaining neurotrophic activity. This patent encompasses neurturin polypeptides, associated nucleic acids that encode the neurturin variants, and vectors and host cells that express the enhanced neurturin polypeptides. This invention holds potential for the treatment or prevention of various diseases, thus showcasing Bespalov's dedication to advancing medical science.
Career Highlights: Maxim Bespalov has worked with prominent companies in the field, including Genecode AS and NTF Therapeutics, Inc. His work experience has provided him with a solid foundation to build upon in developing transformative solutions for neurological challenges.
Collaborations: Throughout his career, Bespalov has collaborated with esteemed professionals in the field, including Mart Saarma and Mati Karelson. These partnerships have fostered a collaborative environment for innovation, encouraging the exchange of ideas and research findings that enhance the development of effective treatments.
Conclusion: Maxim Bespalov's contributions to neurological research through his innovative patents reflect his commitment to improving the lives of individuals affected by neurological disorders. His work not only demonstrates the power of invention but also highlights the importance of collaboration in driving scientific advancements.